This article is more than 5 years old. Information may no longer be current.

FDA approves new lens material from Valeant, B + L

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Valeant Pharmaceuticals International Inc. and Bausch + Lomb have received marketing clearance from the U.S. Food and Drug Administration for Bausch + Lomb’s newest frequent replacement silicone hydrogel contact lens, according to a company press release.

This new monthly disposable silicone hydrogel lens incorporates Bausch + Lomb’s MoistureSeal Technology, the release said.

“We are encouraged to receive this significant marketing clearance much sooner than originally expected,” J. Michael Pearson, chairman and chief executive officer of Valeant, said in the release. “When paired with Biotrue OneDay, we believe this new technology will begin to build an improved contact lens business by providing contact lens wearers with unsurpassed comfort and vision throughout the day.”

Valeant and Bausch + Lomb will announce a launch date soon, according to a company spokesperson.